Coriolis Pharma will launch operations at its currently expanded ATMP development facilities by Q4/2021.
Up To Date
Latest News
Company seeks new opportunities for use of mRNA therapeutics.
U.S. government to purchase at not-for-profit price 200 million doses in 2021 and 300 million in the first...
Funding to accelerate clinical progression of Iksuda's pipeline of new generation of antibody drug...
Lonza will expand its production capacity of Moderna’s mRNA vaccine mRNA1273 at its manufacturing site in...
The European Medicines Agency (EMA) has given the green light for vaccination of adolescents with Biontech's...